The Medicare Patient Access and Practice Stabilization Act of 2025 would fully offset the harmful 2.8% cut in the MPFS and include an additional 2% payment update to physician services furnished after April 1.
President’s Corner: An Open Invitation to Join Our Team
Who is the newest ACR, ARP or Rheumatology Research Foundation volunteer? Hopefully you. Volunteers, working side by side with staff, move the ACR forward. They are the voice through which our mission is put into action, ensuring we meet our members’ goals. Developing an effective pipeline of future volunteer leaders is essential to the future…
Rheuminations: How to Counteract Patients’ Eroding Trust in Healthcare
At first, there was an incomprehensibly loud explosion. And out of that explosion, about 4.5 billion years afterward, emerged the world’s first rheumatologist. Only a few notable things have happened between these two events, but the most important dynamic has been the continuous expansion of our universe. If the speculations of many cosmologists are correct,…
Cancer & RA Drugs: Are Some Drugs Riskier than Others?
Sendaydiego et al. asked: Do some DMARDs pose a greater cancer risk than others for patients with RA? Here are insights from the study and its clinical implications.
mRNA CAR T Cell Therapy Receives FDA’s Rare Pediatric Designation to Treat Juvenile Dermatomyositis
FDA has granted Descartes-08, an mRNA chimeric antigen receptor T cell therapy, a rare pediatric disease designation for the treatment of juvenile dermatomyositis.
Reproductive Health, Biosimilars & More in Focus at SOTA 2025
Reproductive health, biosimilars, IgG4-related disease and much more—five speakers give us a sneak peek into important topics being addressed at the ACR’s 2025 State-of-the-Art Clinical Symposium, April 4–6.
Answering the Call: Anisha Dua, MD, MPH, Looks Ahead to New Role on Committee on Training
Building on her experiences in her practice and through the ACR, this rheumatology leader and educator is eager to advance the work of the COT.
Through Thick & Thin: Updates in Scleroderma
Pulmonary hypertension and Raynaud’s phenomenon are just some of the symptoms patients with systemic sclerosis (SSc) may experience. Here are insights into the diagnosis and management of SSc.
Can MRI Predict Osteoarthritis’ Progression?
In individuals without radiographic knee osteoarthritis (OA), Chang et al. investigated whether magnetic resonance imaging (MRI) defined knee OA at baseline was associated with incident radiographic and symptomatic disease during up to 11 years of follow-up. The researchers found the two current MRI definitions of knee OA may not adequately predict the development of radiographic and symptomatic disease.
Small Postcard, Big Impact: ACR’s New Grassroots Group Empowers Members to Be Rheumatology Advocates
Helping ACR/ARP members talk to lawmakers about rheumatology-related policy is a key part of the ACR’s advocacy efforts. A postcard-writing campaign to Congress highlights outreach efforts of a new member engagement working group.
- « Previous Page
- 1
- …
- 7
- 8
- 9
- 10
- 11
- …
- 815
- Next Page »